Back to search
FDAFDA · Food and drugs·Recall number D-0280-2025

Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93

Published March 26, 2025 · Recall initiated: February 25, 2025

Summary

FDA records drug Class II recall D-0280-2025, published March 26, 2025 and initiated February 25, 2025. Recalling firm: MYLAN PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: N/A; Lot: Lot # 3211073, 3211074, 3211075, Exp 4/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications - low dissolution results

What to do

Voluntary: Firm initiated · Letter

Get an email if PRASUGREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRASUGREL
Manufacturer
MYLAN PHARMACEUTICALS INC
Distributor
US Nationwide.
UPC
0303785185932
Lot
Lot # 3211073, 3211074, 3211075, Exp 4/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93 recalled?

Yes. FDA published recall D-0280-2025 on March 26, 2025. Reported hazard: Failed Dissolution Specifications - low dissolution results

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRASUGREL. UPC: 0303785185932.